Copart (CPRT) CEO exercises 46,757 options, sells 27,745 shares

Q: What insider transactions did Copart (CPRT) CEO Jeffrey Liaw report on July 28, 2026?

Jeffrey Liaw reported option exercises and a share sale dated July 28, 2026. He exercised options into common stock and sold 27,745 shares , reflecting a mix of acquisitions from exercises and a disposition through the sale.

Q: How many Copart (CPRT) shares did Jeffrey Liaw acquire through option exercises?

Jeffrey Liaw exercised stock options into 46,757 shares of Copart common stock. These exercises came from two option grants with strike prices of $6.78 and $8.70 per share, originally granted in 2017 and 2018 with multi‑year vesting schedules.

Q: How many Copart (CPRT) shares did Jeffrey Liaw sell and at what price?

Jeffrey Liaw sold 27,745 shares of Copart common stock at a price of $30.49 per share. The transaction is coded as a sale of non‑derivative common stock and is part of the activity reported for July 28, 2026.

Q: Was the Copart (CPRT) CEO’s sale of 27,745 shares under a Rule 10b5-1 plan?

Yes. The sale of 27,745 shares occurred automatically pursuant to a Rule 10b5-1 trading plan . The footnote states this plan was adopted by Jeffrey Liaw on April 15, 2025, indicating the disposal followed a pre‑established trading schedule.

Q: What are the strike prices of the Copart (CPRT) options Jeffrey Liaw exercised?

The exercised stock options had strike prices of $6.78 and $8.70 per share. One grant dated from October 10, 2017 and the other from October 4, 2018, each vesting 20% after one year and the balance monthly over 48 months.

Q: How did the Copart (CPRT) CEO’s stock options vest according to the filing?

For both reported grants, 20% of the options vested on the first anniversary of the grant date. The remaining 80% vested on a monthly basis over the subsequent 48 months , reflecting a long‑term, time‑based vesting structure for the awards.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Copart Inc. Chief Executive Officer Jeffrey Liaw reported option-related transactions dated July 28, 2026. He exercised stock options to acquire 46,757 shares of common stock at strike prices of $6.78 and $8.70 per share, and sold 27,745 shares at $30.49 per share. The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted on April 15, 2025. The exercised options came from 2017 and 2018 grants that vested 20% after one year and the remainder monthly over 48 months.

Insider Trade Summary 10b5-1

Exercise and sale activity reported; no spread calculated

Exercise and Sale 5 txns

Insider Liaw Jeffrey

Role Chief Executive Officer

Sold 27,745 shs ($846K)

Approx. gross sale proceeds $846K

Approx. exercise cost $400K

Type	Security	Shares	Price	Value
Exercise	Stock Option ^F2	3,591	$0.00	$0.00
Exercise	Stock Option ^F3	43,166	$0.00	$0.00
Exercise	Common Stock	3,591	$6.78	$24K
Exercise	Common Stock	43,166	$8.70	$376K
Sale	Common Stock ^F1	27,745	$30.49	$846K

Holdings After Transaction: Stock Option — 178,718 shares (Direct); Common Stock — 99,641 shares (Direct)

Footnotes (3)

F1. The reported sale of 27,745 shares occurred automatically pursuan to a Rule 10b5-1 trading plan adopted by the reporting person on April 15, 2025.
F2. Twenty percent (20%) of the options vested on the first anniversary of the grant date (October 10, 2017) and the balance vested on a monthly basis over the 48 months succeeding such first anniversary.
F3. Twenty percent (20%) of the options vested on the first anniversary of the grant date (October 4, 2018) and the balance vested on a monthly basis over the 48 months succeeding such first anniversary.

Key Figures

Shares sold: 27,745 shares Sale price: $30.49 per share Options exercised (shares): 46,757 shares +5 more

8 metrics

Shares sold 27,745 shares Common stock sale on 2026-07-28 at $30.49 per share

Sale price $30.49 per share Price for 27,745 common shares sold on 2026-07-28

Options exercised (shares) 46,757 shares Total shares from option exercises reported in transaction summary

Option strike price 1 $6.78 per share Conversion or exercise price for 3,591 underlying shares

Option strike price 2 $8.70 per share Conversion or exercise price for 43,166 underlying shares

10b5-1 plan adoption date April 15, 2025 Date CEO adopted trading plan covering the 27,745-share sale

Initial vesting percentage 20% Portion of options vesting on first anniversary of 2017 and 2018 grants

Remaining vesting period 48 months Remaining options vested monthly over 48 months after first anniversary

Key Terms

Rule 10b5-1 trading plan, Exercise or conversion of derivative security, vested, grant date

4 terms

Rule 10b5-1 trading plan regulatory

"occurred automatically pursuan to a Rule 10b5-1 trading plan adopted"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

Exercise or conversion of derivative security financial

"transaction code description: Exercise or conversion of derivative security"

vested financial

"Twenty percent (20%) of the options vested on the first anniversary"

grant date financial

"vested on the first anniversary of the grant date (October 10, 2017)"

The grant date is the day a company formally gives an employee or contractor the right to receive stock-based compensation, such as stock options or restricted shares. It matters to investors because it fixes key terms—like the price, the start of the ownership clock, and when the award will affect the company’s financial statements and share count—so it can influence dilution, reported expenses, and potential future selling pressure.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/30/2026 - 08:07 PM Accepted by SEC EDGAR 07/30/2026 - 08:07 PM

FAQ

What insider transactions did Copart (CPRT) CEO Jeffrey Liaw report on July 28, 2026?

Jeffrey Liaw reported option exercises and a share sale dated July 28, 2026. He exercised options into common stock and sold 27,745 shares, reflecting a mix of acquisitions from exercises and a disposition through the sale.

How many Copart (CPRT) shares did Jeffrey Liaw acquire through option exercises?

Jeffrey Liaw exercised stock options into 46,757 shares of Copart common stock. These exercises came from two option grants with strike prices of $6.78 and $8.70 per share, originally granted in 2017 and 2018 with multi‑year vesting schedules.

How many Copart (CPRT) shares did Jeffrey Liaw sell and at what price?

Jeffrey Liaw sold 27,745 shares of Copart common stock at a price of $30.49 per share. The transaction is coded as a sale of non‑derivative common stock and is part of the activity reported for July 28, 2026.

Was the Copart (CPRT) CEO’s sale of 27,745 shares under a Rule 10b5-1 plan?

Yes. The sale of 27,745 shares occurred automatically pursuant to a Rule 10b5-1 trading plan. The footnote states this plan was adopted by Jeffrey Liaw on April 15, 2025, indicating the disposal followed a pre‑established trading schedule.

What are the strike prices of the Copart (CPRT) options Jeffrey Liaw exercised?

The exercised stock options had strike prices of $6.78 and $8.70 per share. One grant dated from October 10, 2017 and the other from October 4, 2018, each vesting 20% after one year and the balance monthly over 48 months.

How did the Copart (CPRT) CEO’s stock options vest according to the filing?

For both reported grants, 20% of the options vested on the first anniversary of the grant date. The remaining 80% vested on a monthly basis over the subsequent 48 months, reflecting a long‑term, time‑based vesting structure for the awards.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Liaw Jeffrey

(Last)

(First)

(Middle)

COPART, INC. 14185 DALLAS PARKWAY

SUITE 300

(Street)

DALLAS

TEXAS

75254

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
COPART INC [ CPRT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/28/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	07/28/2026		M		3,591	A	$6.78	84,220	D
Common Stock	07/28/2026		M		43,166	A	$8.7	127,386	D
Common Stock	07/28/2026		S		27,745⁽¹⁾	D	$30.49	99,641	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option	$6.78	07/28/2026		M			3,591	⁽²⁾	10/10/2026	Common Stock	3,591	$0	0	D
Stock Option	$8.7	07/28/2026		M			43,166	⁽³⁾	10/04/2027	Common Stock	43,166	$0	178,718	D

Explanation of Responses:

1. The reported sale of 27,745 shares occurred automatically pursuan to a Rule 10b5-1 trading plan adopted by the reporting person on April 15, 2025.

2. Twenty percent (20%) of the options vested on the first anniversary of the grant date (October 10, 2017) and the balance vested on a monthly basis over the 48 months succeeding such first anniversary.

3. Twenty percent (20%) of the options vested on the first anniversary of the grant date (October 4, 2018) and the balance vested on a monthly basis over the 48 months succeeding such first anniversary.

	/s/ D. Joseph Meister, attorney-in-fact	07/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR